Avalo Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2017

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Avalo Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2017.
  • Avalo Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -6.67K %, a 5365% decline year-over-year.
  • Avalo Therapeutics, Inc. annual Operating Margin for 2017 was 49.9 %.
Operating Margin, Annual (%)
Period Value YoY Chg Change % Start Date End Date
2017 49.9 +1.44K Jan 1, 2017 Dec 31, 2017
2016 -1.39K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.